Article Content
Abstract
Background
Accurate estimation of renal function is essential for determining vancomycin (VCM) dosing. Serum creatinine (sCr)-based formulas are used to estimate renal function; however, they may overestimate the glomerular filtration rate (GFR) in patients with reduced muscle mass. Serum cystatin C (cys-C) may provide more accurate estimates of renal function in such populations.
Aim
We aimed to investigate the effect of estimated GFR (eGFR) discordance on area under the blood concentration–time curve (AUC) of VCM.
Method
Data from 118 patients with simultaneous sCr and cys-C data available at start of VCM therapy were analyzed. Patients were classified into eGFR discordance and concordance groups. eGFR discordance was defined as a case where the sCr-based eGFR was 30% or higher than the cys-C-based eGFR. The primary outcome was the association between eGFR discordance and upward deviation of the VCM AUC.
Results
Seventy-two patients with eGFR discordance had significantly higher measurement of VCM AUC than predicted (p < 0.001). Multivariate logistic regression analysis identified age, hospital stay of ≥ 12 days, and eGFR discordance as significant predictors of AUC upward deviation. Factors associated with discordance in the eGFR included these risk factors and intensive care unit (ICU) stay.
Conclusion
This study highlights the importance of measuring cys-C levels at initiation of VCM therapy identifying patients at risk of renal function overestimation and subsequent VCM overdosing. Older with extended hospitalization or ICU stay may benefit from measuring cys-C levels of optimize VCM therapy and reduce drug-induced toxicity risk.
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.
References
-
Tsutsuura M, Moriyama H, Kojima N, et al. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing. BMC Infect Dis. 2021;21:153. https://doi.org/10.1186/s12879-021-05858-6.
-
Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health System Pharmacists. Clin Infect Dis. 2020;71:1361–4. https://doi.org/10.1093/cid/ciaa303.
-
Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–70. https://doi.org/10.7326/0003-4819-130-6-199903160-00002.
-
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41. https://doi.org/10.1159/000180580.
-
Oda K, Katanoda T, Hashiguchi Y, et al. Development and evaluation of a vancomycin dosing nomogram to achieve the target area under the concentration-time curve. A retrospective study. J Infect Chemother. 2020;26:444–50. https://doi.org/10.1016/j.jiac.2019.11.009.
-
Takigawa M, Tanaka H, Obara T, et al. Utility of the Berlin Initiative Study-1 equation for the prediction of serum vancomycin concentration in elderly patients aged 75 years and older. Pharmazie. 2022;77:76–80. https://doi.org/10.1691/ph.2022.1972.
-
Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385:1737–49. https://doi.org/10.1056/NEJMoa2102953.
-
Shafi T, Zhu X, Lirette ST, et al. Quantifying individual-level inaccuracy in glomerular filtration rate estimation: a cross-sectional study. Ann Intern Med. 2022;175:1073–82. https://doi.org/10.7326/M22-0610.
-
Ishigo T, Ibe Y, Fujii S, et al. Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients. J Infect Chemother. 2023;29:769–77. https://doi.org/10.1016/j.jiac.2023.04.018.
-
Haines RW, Fowler AJ, Liang K, et al. Comparison of cystatin C and creatinine in the assessment of measured kidney function during critical illness. Clin J Am Soc Nephrol. 2023;18:997–1005. https://doi.org/10.2215/CJN.0000000000000203.
-
Teaford HR, Stevens RW, Rule AD, et al. Prediction of vancomycin levels using cystatin C in overweight and obese patients: a retrospective cohort study of hospitalized patients. Antimicrob Agents Chemother. 2020;65:e01487-e1520. https://doi.org/10.1128/AAC.01487-20.
-
Frazee E, Rule AD, Lieske JC, et al. Cystatin C-guided vancomycin dosing in critically ill patients: a quality improvement project. Am J Kidney Dis. 2017;69:658–66. https://doi.org/10.1053/j.ajkd.2016.11.016.
-
Barreto EF, Rule AD, Murad MH, et al. Prediction of the renal elimination of drugs with cystatin C vs creatinine: a systematic review. Mayo Clin Proc. 2019;94:500–14. https://doi.org/10.1016/j.mayocp.2018.08.002.
-
Hanna PE, Wang Q, Strohbehn IA, et al. Medication-related adverse events and discordancies in cystatin C-based vs serum creatinine-based estimated glomerular filtration rate in patients with cancer. JAMA Netw Open. 2023;6:e2321715. https://doi.org/10.1001/jamanetworkopen.2023.21715.
-
Costa e Silva VT, Gil LA Jr, Inker LA, et al. A prospective cross-sectional study estimated glomerular filtration rate from creatinine and cystatin C in adults with solid tumors. Kidney Int. 2022;101:607–14. https://doi.org/10.1016/j.kint.2021.12.010.
-
Delgado C, Baweja M, Crews DC, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease. J Am Soc Nephrol. 2021;32:2994–3015. https://doi.org/10.1681/ASN.2021070988.
-
Oda K, Hashiguchi Y, Kimura T, et al. Performance of area under the concentration-time curve estimations of vancomycin with limited sampling by a newly developed web application. Pharm Res. 2021;38:637–46. https://doi.org/10.1007/s11095-021-03030-y.
-
Inker LA, Eckfeldt J, Levey AS, et al. Expressing the CKD-EPI (chronic kidney disease epidemiology collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis. 2011;58:682–4. https://doi.org/10.1053/j.ajkd.2011.05.019.
-
Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51:395–406. https://doi.org/10.1053/j.ajkd.2007.11.018.
-
Delgado C, Baweja M, Crews DC, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease. Am J Kidney Dis. 2022;79:268-288.e1. https://doi.org/10.1053/j.ajkd.2021.08.003.
-
Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92. https://doi.org/10.1053/j.ajkd.2008.12.034.
-
Horio M, Imai E, Yasuda Y, et al. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis. 2013;61:197–203. https://doi.org/10.1053/j.ajkd.2012.07.007.
-
Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition. 1989;5(5):303–11 (discussion 312–3).
-
Ibe Y, Ishigo T, Fujii S, et al. Simulation of vancomycin exposure using trough and peak levels achieves the target area under the steady-state concentration-time curve in ICU patients. Antibiotics (Basel). 2023;12:1113. https://doi.org/10.3390/antibiotics12071113.
-
Baxmann AC, Ahmed MS, Marques NC, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008;3:348–54. https://doi.org/10.2215/CJN.02870707.
-
Chew-Harris JS, Florkowski CM, George PM, et al. The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men. Ann Clin Biochem. 2013;50:39–46. https://doi.org/10.1258/acb.2012.011241.
-
Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47. https://doi.org/10.1001/jama.298.17.2038.
-
Stevens LA, Li S, Wang C, et al. Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2010;55(Suppl 2):S23-33. https://doi.org/10.1053/j.ajkd.2009.09.035.
-
Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8:117. https://doi.org/10.1186/1471-2458-8-117.
-
Ballew SH, Zhou L, Surapaneni A, et al. A novel creatinine muscle index based on creatinine filtration: associations with frailty and mortality. J Am Soc Nephrol. 2023;34:495–504. https://doi.org/10.1681/ASN.0000000000000037.
-
Chen DC, Lu K, Scherzer R, et al. Cystatin C- and creatinine-based estimated GFR differences: prevalence and predictors in the UK Biobank. Kidney Med. 2024;6: 100796. https://doi.org/10.1016/j.xkme.2024.100796.
-
Prado CM, Purcell SA, Alish C, et al. Implications of low muscle mass across the continuum of care: a narrative review. Ann Med. 2018;50:675–93. https://doi.org/10.1080/07853890.2018.1511918.
-
Kashani KB, Frazee EN, Kukrálová L, et al. Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index. Crit Care Med. 2017;45:e23–9. https://doi.org/10.1097/CCM.0000000000002013.
-
Lin YL, Chen SY, Lai YH, et al. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease. Clin Nutr. 2020;39(8):2435–41. https://doi.org/10.1016/j.clnu.2019.10.027.
-
Martone AM, Bianchi L, Abete P, et al. The incidence of sarcopenia among hospitalized older patients: results from the Glisten study. J Cachexia Sarcopenia Muscle. 2017;8:907–14. https://doi.org/10.1002/jcsm.12224.
-
Udy AA, Roberts JA, Boots RJ, et al. Augmented renal clearance: implications for antibacterial dosing in the critically ill. Clin Pharmacokinet. 2010;49:1–16. https://doi.org/10.2165/11318140-000000000-00000.
-
Steinke T, Moritz S, Beck S, et al. Estimation of creatinine clearance using plasma creatinine or cystatin C: a secondary analysis of two pharmacokinetic studies in surgical ICU patients. BMC Anesthesiol. 2015;15:62. https://doi.org/10.1186/s12871-015-0043-7.
-
Ishigo T, Matsumoto K, Yoshida H, et al. Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study. Microbiol Spectr. 2024;12(7): e0373923. https://doi.org/10.1128/spectrum.03739-23.
Acknowledgements
We would like to express our sincere gratitude to all the patients and medical staff who contributed to this study. Special thanks are extended to the clinical pharmacists and laboratory teams for their invaluable support in data collection and analysis.
Funding
The authors declare that no funds, grants, or other support was received during the preparation of this manuscript.
Ethics declarations
Conflicts of interest
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ibe, Y., Ishigo, T., Aigami, T. et al. Effect of discrepancy in estimated renal function on vancomycin area under the blood concentration–time curve: a retrospective cohort study comparing serum creatinine and serum cystatin C. Int J Clin Pharm (2025). https://doi.org/10.1007/s11096-025-01960-w
- Received
- Accepted
- Published
- DOI https://doi.org/10.1007/s11096-025-01960-w